⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. XIFAXAN® (rifaximin) For Adults with Overt HE and IBS just got measured.
5/10 means XIFAXAN® (rifaximin) For Adults with Overt HE and IBS is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence and for the treatment of IBS-D in adults. See Important Safety Information and full Prescribing Information on website.
Industry: Healthcare
xifaxan.com1
Structured Data
5
Content Structure
6
Entity Clarity
5
E-E-A-T Signals
7
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for XIFAXAN® (rifaximin) For Adults with Overt HE and IBS.
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/xifaxan
Cite this score: Engagemii (2026). "AEO Score for XIFAXAN® (rifaximin) For Adults with Overt HE and IBS." Retrieved from https://engagemii.com/aeo/brands/xifaxan
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform